In vitro characterization of the biomimetic properties of poly (dimethylsiloxane) to simulate oral drug absorption

PD Sinko, D Gidley, R Vallery… - Molecular …, 2017 - ACS Publications
The potential use of poly (dimethylsiloxane)(PDMS) as an in vitro biomimetic analogue of
the passive drug absorption process in the human gastrointestinal tract (GI) is assessed …

Physiologically based in vitro models to predict the oral dissolution and absorption of a solid drug delivery system

Z Li, X He - Current Drug Metabolism, 2015 - ingentaconnect.com
To understand the sophisticated dynamic behaviors of drug elution and permeation in the
gastrointestinal tract (GIT), researchers have tried to reemerge it by employing various in …

Analysis of the complicated nonlinear pharmacokinetics of orally administered telmisartan in rats using a stable isotope-IV method

K Minami, H Higashino, M Kataoka, K Togashi… - Journal of …, 2019 - Elsevier
This study aimed to kinetically analyze the nonlinear absorption and systemic exposure of
telmisartan (TEL) after oral administration to rats by using a stable isotope-IV method. Rats …

Evaluation of dose-dependent oral absorption of a newly developed drug candidate: in vitro-in vivo correlation

K Yano, M Kataoka, S Ono, M Hiramatsu… - Journal of Drug Delivery …, 2016 - Elsevier
ONO-5129 is a dual agonist of peroxisome proliferator-activated receptors (PPARs) α and γ
with poor water solubility. To assess the clinical “developability” of this drug candidate, we …

[HTML][HTML] 基于胃肠道生理驱动的药物溶出/透过特征同步评价技术研究进展

李自强, 何新, 刘昌孝 - 药学学报, 2016 - html.rhhz.net
口服药物制剂在胃肠道的溶出和吸收过程, 是一个连续, 动态, 同步进行的动力学过程,
影响着体内生物利用度. 药物溶出/透过同步评价技术将体外溶出模型和跨膜透过模型有机结合 …

[HTML][HTML] Development of a child-appropriate drug formulation for poorly soluble protease inhibitors for HIV treatment in children

M Kokott - docserv.uni-duesseldorf.de
Beschreibungen: Seit dem Paradigmenwechsel von den früher bevorzugten flüssigen
Darreichungsformen zu festen Darreichungsformen für pädiatrische Patienten sind …

[PDF][PDF] Bioavailability, Bioequivalence, and Pharmacokinetics: Clinical Effectiveness in Drug Development

GME Hussein, HS Ali, BM Elhaj - Acta Scientific Pharmaceutical …, 2021 - academia.edu
Bioequivalence has also been referred to as comparative bioavailability. The concept of
bioequivalence started gaining an increased attention during the last three decades, after it …

Mechanistic understanding of bioenabling formulation approaches to improve oral bioavailability using porcine in vivo and in silico models

JP O'Shea - 2018 - cora.ucc.ie
Objectives: Mesoporous silicas (SLC) have demonstrated considerable potential to improve
bioavailability of poorly soluble drugs by facilitating rapid dissolution and generating …

Diagnosing biopharmaceutical limitations

SM Jenkins, DD Parker - … and Developing Molecules with Optimal Drug …, 2014 - Springer
Obtaining optimal oral exposure in the drug discovery process can be a challenging goal for
the discovery team, especially when the target therapy demands adequate exposure …

Characterization of the Partition Rate of 2-Naphthol (NAP) and Ritonavir (RTV) Across the Water-Octanol Interface and the Influence of Common Pharmaceutical …

W Wang, S Vela, P Gao - Journal of Pharmaceutical Sciences, 2020 - Elsevier
The partition rate of 2 model compounds, 2-naphthol (NAP) and ritonavir (RTV), across the
water-octanol (W/O) interface was determined from aqueous solutions with and without the …